VistaGen Therapeutics Inc Stock Forecast
VistaGen Therapeutics Inc stock upgraded from Sell Candidate to Hold/Accumulate after Thursday trading session.
(Updated on Apr 18, 2024)
The VistaGen Therapeutics Inc stock price gained 0.642% on the last trading day (Thursday, 18th Apr 2024), rising from $4.67 to $4.70. During the last trading day the stock fluctuated 4.78% from a day low at $4.60 to a day high of $4.82. The price has been going up and down for this period, and there has been a -11.15% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 79 thousand more shares were traded than the day before. In total, 193 thousand shares were bought and sold for approximately $908.82 thousand.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.24% during the next 3 months and, with a 90% probability hold a price between $3.79 and $5.26 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
VTGN Signals & Forecast
The VistaGen Therapeutics Inc stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $4.87. On a fall, the stock will find some support from the long-term average at approximately $4.66. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Tuesday, April 16, 2024, and so far it has risen 1.08%. Further rise is indicated until a new top pivot has been found. VistaGen Therapeutics Inc has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for VistaGen Therapeutics Inc stock
VistaGen Therapeutics Inc finds support from accumulated volume at $4.49 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.220 between high and low, or 4.78%. For the last week, the stock has had daily average volatility of 7.00%.
Our recommended stop-loss: $4.42 (-5.91%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 2 days ago.)
Trading Expectations (VTGN) For The Upcoming Trading Day Of Friday 19th
For the upcoming trading day on Friday, 19th we expect VistaGen Therapeutics Inc to open at $4.71, and during the day (based on 14 day Average True Range), to move between $4.37 and $5.03, which gives a possible trading interval of +/-$0.326 (+/-6.93%) up or down from last closing price. If VistaGen Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 13.86% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $4.85 (3.19%) than the support at $4.49 (4.47%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is VistaGen Therapeutics Inc stock A Buy?
VistaGen Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.
Current score: -0.529 Hold/Accumulate Upgraded
Predicted Opening Price for VistaGen Therapeutics Inc of Friday, April 19, 2024
Fair opening price April 19, 2024 | Current price |
---|---|
$4.71 ( 0.142%) | $4.70 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for VTGN
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 4.93 | 4.82 % | |
R2 | 4.84 | 3.03 % | ||
R1 | 4.79 | 1.93 % | ||
Current price: | 4.70 | |||
Support | S1 | 4.62 | -1.65 % | |
S2 | 4.57 | -2.75 % | ||
S3 | 4.49 | -4.54 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 5.40 | 14.89 % | |
R2 | 5.28 | 12.34 % | ||
R1 | 4.85 | 3.19 % | ||
Current price | 4.70 | |||
Support | S1 | 4.49 | -4.47% | |
S2 | 4.24 | -9.89% | ||
S3 | 4.17 | -11.28% |
FAQ
Click here for our free guide on how to buy VistaGen Therapeutics Inc Stock.